(Q41061878)

26 September 2017

1 reference

title

Two faces of cholecystokinin: anxiety and schizophrenia (English)

1 reference

26 September 2017

0 references

1 reference

Bourin M

1

1 reference

26 September 2017

Malinge M

series ordinal

2

1 reference

26 September 2017

Vasar E

series ordinal

3

1 reference

26 September 2017

Bradwejn J

series ordinal

4

1 reference

26 September 2017

1 January 1996

1 reference

Fundamental and Clinical Pharmacology

26 September 2017

1 reference

26 September 2017

10

1 reference

26 September 2017

116-126

1 reference

26 September 2017

2

1 reference

Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus

26 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1996.TB00154.X

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1996.TB00154.X

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1996.TB00154.X

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1996.TB00154.X

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1996.TB00154.X

10.1111/J.1472-8206.1996.TB00154.X

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference